Lumexa Imaging Holdings, Inc. is a provider of diagnostic imaging services operating a network of outpatient imaging centers across the United States. The company offers magnetic resonance imaging (MRI), computed tomography (CT), and other advanced imaging modalities through its freestanding centers, which are located in metropolitan service areas. Lumexa Imaging serves patients and referring physicians, and it maintains joint venture partnerships with health systems. The company utilizes third-party technology for radiology information systems, picture archiving and communication systems, and revenue cycle management, and it is implementing artificial intelligence solutions to enhance clinical efficiency and patient scheduling. Established in 2018 as US Radiology Specialists by Charlotte Radiology and Welsh, Carson, Anderson & Stowe, the company changed its name to Lumexa Imaging Equity Holdco, LLC in 2025. Lumexa Imaging Holdings, Inc. was incorporated in November 2025 and completed its initial public offering during the same year.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Medical Care Facilities Homepage ir.lumexaimaging.com
Sector Healthcare IR page ir.lumexaimaging.com
Tags
diagnostic imaging, outpatient imaging centers, mri, ct, radiology information systems, picture archiving and communication systems, revenue cycle management, artificial intelligence, health system joint ventures, Lumexa Imaging Equity Holdco LLC, US Radiology Specialists, Charlotte Radiology, Welsh Carson Anderson & Stowe
Press page —

Metrics

Valuation  
Market cap —
Market cap (USD) —
P/E —
PEG —
P/BV —
P/S —
P/OCF —
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE —
ROI —
ROIC —
Profit margin —
Growth  
Revenue growing —
Profits growing —
Revenue up 3y —
Revenue up 5y —
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable —
Margin expanding —
Buying back stock —
Diluting (TTM) —
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 27
Quality score —
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure Q3 2026 Q2 2026 Q1 2026
Revenue 271.973M 264.162M 252.537M
Net profit 7.178M 2.745M 1.717M
Free cash flow 20.604M 23.13M -2.382M

Figure Q3 2026 Q2 2026 Q1 2026
Share price 10.25 11.28 8.6
P/FCF 11.95 11.71 -86.72

Filed figures

Figure Dec 2024 Dec 2025
Balance sheet detail
Borrowings, current (USD) — 13.1M
Borrowings, non-current (USD) — 819M
Lease liabilities (USD) — 129M
Cash and deposits (USD) 26.1M 58.8M
Intangible assets (USD) — 41.3M
Right-of-use assets (USD) — 76.6M
Net debt (borrowings + leases - cash) (USD) — 902M
Reported May 12, 2026 May 12, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Lumexa Imaging Announces Third Quarter 2026 Results Bull 4 Bear 0 Results

RALEIGH, N. C., November 10, 2026—Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, today reported results for the third quarter ended September 30, 2026.

“In Q3, we advanced our business in several meaningful ways while executing against our strategy. Advanced modalities reached a record high as a percent of our volumes, and our newer de novo cohorts continue to ramp on plan. We are actively opening three new de novo centers and are on pace to achieve our goal for 8–10 new center openings this year,” said Caitlin Zulla, Chief Executive Officer of Lumexa Imaging. “These achievements mark progress toward our long-term growth plans, and that progress is translating into strong, durable cash generation.

October 28, 2026

PDF Version

RALEIGH, N.C., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, today announced it will release its third quarter 2026 financial and operational results after market close on Tuesday, November 10, 2026. The Company will host a conference call and live webcast to discuss the results at 5:00 p.m. ET.

The live audio webcast will be available in the Investor Relations section of the Company’s website at ir.lumexaimaging.com. A replay of the webcast will be available for approximately one year.

About Lumexa Imaging

Lumexa Imaging is a nationwide provider of outpatient medical imaging. With over 5,000 team members and approximately 190 outpatient imaging centers, our team conducted approximately 4 million outpatient procedures system-wide in 2025. We are a partner of choice for health systems and radiologists, delivering best-in-class clinical excellence, operations, and state-of-the-art technology across our platform.

Media Contact Melissa Weston [email protected]

IR Contact Sue Dooley [email protected]

Search Investors

August 25, 2026

PDF Version

RALEIGH, N.C., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging Holdings, Inc. (“Lumexa Imaging”) (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, announced today that Caitlin Zulla, CEO, and Tony Martin, CFO, will participate in the following upcoming investor conferences:

  • Wells Fargo 21st Annual Healthcare Conference, held in Boston, including a fireside chat at 3:00 PM ET and one-on-one meetings with Caitlin Zulla and Tony Martin on September 9, 2026.

  • JP Morgan High Yield Conference, held in Nashville, with a fireside chat at 11:15 AM and one-on-one meetings with Tony Martin on September 10, 2026.

  • Jefferies Healthcare Conference, held in Nashville, including one-on-one meetings with Tony Martin on September 15, 2026

  • Deutsche Bank’s 2026 Healthcare Summit, held in New York, including one-on-one meetings with Caitlin Zulla on September 16, 2026.

Available webcast links for fireside chats will be online at https://ir.lumexaimaging.com.

ABOUT LUMEXA IMAGING

Lumexa Imaging is a nationwide provider of outpatient medical imaging. With over 5,000 team members and greater than 190 outpatient imaging centers, our team conducted approximately 4 million outpatient procedures system-wide in 2025. We are a partner of choice for health systems and radiologists, delivering best-in-class clinical excellence, operations, and state-of-the-art technology across our platform.

INVESTOR CONTACT

Sue Dooley [email protected]

MEDIA CONTACT

Melissa Weston [email protected]

Forward-Looking Statements This press release and announced conference participation, including related remarks, may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this press release may be forward-looking statements. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," or "will," or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions. Forward-looking statements in this release or resulting conference remarks may include, but are not limited to, statements regarding our expectations regarding our financial position and operating performance, including our guidance for full year 2026 and our assumptions underlying such guidance; our ability to drive future growth and execute on our goals and strategies; and our expectations regarding our product innovation. Our expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including but not limited to those risk factors identified in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of our Annual Report on Form 10-K for the year ended December 31, 2025 and our later dated Quarterly Reports on Form 10-Q, each as filed with the Securities and Exchange Commission. The forward-looking statements in this press release are based on information available to us as of the date hereof, and we disclaim any obligations to update any forward-looking statements, except as required by law.

Search Investors

Prompts

Lumexa Imaging Holdings, Inc. (ticker LMRI), listed in United States.

ETFs Holding Lumexa Imaging Holdings, Inc.

ETF Weight in ETF Shares Market value As of
LFSC 0.91% 98,183 $ 1.146M Aug 31, 2026